Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 4 to 7

Oral vs IV Magnesium for Emergence Delirium in Children after Adenotonsillectomy

Official title: Effect of Oral Versus Intravenous Magnesium on Emergence Delirium in Children Undergoing Adenotonsillectomy: A Two-Center, Randomized, Double-Blind, Placebo-Controlled Study

Run by Tanta University · NCT07655817 · Data updated 2026-11-12

This trial tests whether giving magnesium by mouth before surgery or by IV during surgery can reduce emergence delirium in children aged 4–7 undergoing adenotonsillectomy with sevoflurane anesthesia.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages4 Years to 7 Years
SexAll
Enrollment360 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, Gharbia Governorate)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedDecember 24, 2026
Study endsDecember 25, 2026
Registry record updatedJuly 6, 2026
Trial IDNCT07655817 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 4 to 7 years with ASA I–II status scheduled for adenotonsillectomy under sevoflurane anesthesia.

Probably not a fit

Children with behavioral, neurological, or psychiatric conditions, anticonvulsant or sedative use, or magnesium allergies may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, controlled study comparing two magnesium delivery methods in children undergoing adenotonsillectomy under sevoflurane anesthesia. It aims to see if preoperative oral magnesium or intraoperative IV magnesium lowers the occurrence and severity of emergence delirium. Magnesium is explored for its potential anesthetic- and analgesic-sparing effects and calming properties. The study builds on mixed prior results for IV magnesium and seeks to determine if oral magnesium before induction offers additional benefit. Participants will be ASA I–II and 4–7 years old, with outcomes focused on delirium incidence and severity.

Why it matters

Potential benefit: If successful, the approach could reduce emergence delirium and improve recovery experiences for children undergoing adenotonsillectomy.

How similar studies have gone: Previous studies on IV magnesium have shown inconsistent results; this trial investigates whether alternative timing or route (oral) may provide clearer benefits.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 4 to 7 years
* American Society of Anesthesiologist (ASA) Status I or II
* Planned for an adenotonsillectomy procedure under sevoflurane general anesthesia.

Exclusion Criteria:

* Parents declined to participate in the trial
* Behavioral changes, neurological or psychiatric problems
* Anticonvulsant or sedative drugs
* Physical or developmental abnormalities
* Allergies to magnesium
* cardiovascular, renal, bone, or gastrointestinal diseases.

Where it's running

  • Tanta University Hospitals
    Tanta, Gharbia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.